This list is based on the watchlists of people on Stock Events who follow CMEOF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Creo Medical Limited, a UK-based enterprise and subsidiary of Creo Medical Group plc, specializes in the innovation and creation of electrosurgical medical devices for surgical endoscopy applications. Founded in 2003 as MicroOncology Ltd and headquartered in Chepstow, the company's core offering is Croma, an advanced energy platform. This platform is engineered to power a diverse collection of multi-modal instruments, thereby enhancing therapeutic interventions for both medical professionals and patients. Its extensive product portfolio includes specialized tools such as Speedboat Inject, an adaptable energy instrument designed for flexible endoscopic procedures; Speedboat Slim, a flexible bipolar radiofrequency (RF) and microwave device for precise tissue cutting and coagulation; MicroBlate Fine, a microwave needle for ablation; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device engineered to control upper and lower gastrointestinal bleeds; and SpydrBlade Flex, a flexible scissor-like instrument that integrates bipolar RF and microwave technology to grasp, cut, and coagulate highly vascularized tissues.
FAQs
What is Creo Medical Group stock price today?▼
The current price of CMEOF is $0.15 USD — it has increased by +0% in the past 24 hours. Watch Creo Medical Group stock price performance more closely on the chart.
What is Creo Medical Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Creo Medical Group stocks are traded under the ticker CMEOF.
What is Creo Medical Group market cap?▼
Today Creo Medical Group has the market capitalization of 5.5M
When is the next Creo Medical Group earnings date?▼
Creo Medical Group is going to release the next earnings report on June 2, 2027.
What were Creo Medical Group earnings last quarter?▼
CMEOF earnings for the last quarter are -0.03 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Creo Medical Group revenue for the last year?▼
Creo Medical Group revenue for the last year amounts to 11.9M USD.
What is Creo Medical Group net income for the last year?▼
CMEOF net income for the last year is 7.61M USD.
How many employees does Creo Medical Group have?▼
As of November 6, 2026, the company has 104 employees.
In which sector is Creo Medical Group located?▼
Creo Medical Group operates in the Health & Wellness sector.
When did Creo Medical Group complete a stock split?▼
Creo Medical Group has not had any recent stock splits.
Where is Creo Medical Group headquartered?▼
Creo Medical Group is headquartered in Chepstow, United Kingdom.